177 related articles for article (PubMed ID: 9456270)
1. Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.
Suzuki K; Miura T; Miki T; Tsuchida A; Shimamoto K
J Cardiovasc Pharmacol; 1998 Jan; 31(1):1-9. PubMed ID: 9456270
[TBL] [Abstract][Full Text] [Related]
2. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
Miura T; Miura T; Kawamura S; Goto M; Sakamoto J; Tsuchida A; Matsuzaki M; Shimamoto K
Cardiovasc Res; 1998 Mar; 37(3):700-9. PubMed ID: 9659454
[TBL] [Abstract][Full Text] [Related]
3. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning.
Miura T; Ogawa T; Iwamoto T; Shimamoto K; Iimura O
Circulation; 1992 Sep; 86(3):979-85. PubMed ID: 1516209
[TBL] [Abstract][Full Text] [Related]
4. Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size.
Martin BJ; McClanahan TB; Van Wylen DG; Gallagher KP
Basic Res Cardiol; 1997 Aug; 92(4):240-51. PubMed ID: 9342431
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning with 15-minute ischemia extends myocardial infarct size after subsequent 30-minute ischemia in rabbits.
Yamasaki K; Fujiwara H; Tanaka M; Yokota R; Miyamae M; Ogawa J; Fujiwara T; Sasayama S
Jpn Circ J; 1997 Apr; 61(4):344-52. PubMed ID: 9152787
[TBL] [Abstract][Full Text] [Related]
6. Infarct size limitation by a new Na(+)-H+ exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C.
Miura T; Ogawa T; Suzuki K; Goto M; Shimamoto K
J Am Coll Cardiol; 1997 Mar; 29(3):693-701. PubMed ID: 9060913
[TBL] [Abstract][Full Text] [Related]
7. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
Tanno M; Tsuchida A; Nozawa Y; Matsumoto T; Hasegawa T; Miura T; Shimamoto K
J Cardiovasc Pharmacol; 2000 Mar; 35(3):345-52. PubMed ID: 10710117
[TBL] [Abstract][Full Text] [Related]
8. Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
Mei DA; Nithipatikom K; Lasley RD; Gross GJ
J Mol Cell Cardiol; 1998 Jun; 30(6):1225-36. PubMed ID: 9689596
[TBL] [Abstract][Full Text] [Related]
9. Relationship between free radicals and adenosine in the mechanism of preconditioning: are they interrelated or independent triggers?
Fukuma T; Miura T; Suzuki K; Tsuchida A; Nozawa Y; Shimamoto K
Mol Cell Biochem; 2000 Aug; 211(1-2):51-9. PubMed ID: 11055547
[TBL] [Abstract][Full Text] [Related]
10. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
Toyoda Y; Di Gregorio V; Parker RA; Levitsky S; McCully JD
Circulation; 2000 Nov; 102(19 Suppl 3):III326-31. PubMed ID: 11082409
[TBL] [Abstract][Full Text] [Related]
11. Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart.
Tsuchida A; Miura T; Tanno M; Nozawa Y; Kita H; Shimamoto K
Cardiovasc Drugs Ther; 1998 Sep; 12(4):365-73. PubMed ID: 9825182
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Baxter GF; Marber MS; Patel VC; Yellon DM
Circulation; 1994 Dec; 90(6):2993-3000. PubMed ID: 7994847
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning.
Miura T; Suzuki K; Shimamoto K; Iimura O
Basic Res Cardiol; 1996; 91(6):425-32. PubMed ID: 8996627
[TBL] [Abstract][Full Text] [Related]
14. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
Miki T; Miura T; Ura N; Ogawa T; Suzuki K; Shimamoto K; Iimura O
J Am Coll Cardiol; 1996 Nov; 28(6):1616-22. PubMed ID: 8917279
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection associated with preconditioning in the anesthetized ferret.
Gomoll AW
Basic Res Cardiol; 1996; 91(6):433-43. PubMed ID: 8996628
[TBL] [Abstract][Full Text] [Related]
16. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size.
Lasley RD; Konyn PJ; Hegge JO; Mentzer RM
Am J Physiol; 1995 Oct; 269(4 Pt 2):H1460-6. PubMed ID: 7485581
[TBL] [Abstract][Full Text] [Related]
17. Dilazep dihydrochloride prolongs the infarct size-limiting effect of ischemic preconditioning in rabbits.
Yamasaki K; Tanaka M; Yokota R; Fujiwara H; Sasayama S
Heart Vessels; 2000; 15(5):227-32. PubMed ID: 11560359
[TBL] [Abstract][Full Text] [Related]
18. Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the preconditioning.
Goto M; Miura T; Itoya M; Sakamoto J; Iimura O
Basic Res Cardiol; 1993; 88(6):594-606. PubMed ID: 8147824
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.
Imagawa J; Baxter GF; Yellon DM
J Cardiovasc Pharmacol; 1998 Jan; 31(1):74-9. PubMed ID: 9456280
[TBL] [Abstract][Full Text] [Related]
20. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
Tsuchida A; Miura T; Miki T; Shimamoto K; Iimura O
Cardiovasc Res; 1992 May; 26(5):456-61. PubMed ID: 1446315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
